DNA methylation-based classification of central nervous system tumours D Capper, DTW Jones, M Sill, V Hovestadt, D Schrimpf, D Sturm, ... Nature 555 (7697), 469-474, 2018 | 2376 | 2018 |
Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma D Sturm, H Witt, V Hovestadt, DA Khuong-Quang, DTW Jones, ... Cancer cell 22 (4), 425-437, 2012 | 1986 | 2012 |
An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor CA Opitz, UM Litzenburger, F Sahm, M Ott, I Tritschler, S Trump, ... Nature 478 (7368), 197-203, 2011 | 1897 | 2011 |
Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high-grade gliomas S Bender, Y Tang, AM Lindroth, V Hovestadt, DTW Jones, M Kool, ... Cancer cell 24 (5), 660-672, 2013 | 772 | 2013 |
Stem cell marker CD133 affects clinical outcome in glioma patients F Zeppernick, R Ahmadi, B Campos, C Dictus, BM Helmke, N Becker, ... Clinical cancer research 14 (1), 123-129, 2008 | 746 | 2008 |
A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon K Fellermann, DE Stange, E Schaeffeler, H Schmalzl, J Wehkamp, ... The American Journal of Human Genetics 79 (3), 439-448, 2006 | 715 | 2006 |
BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas S Pfister, WG Janzarik, M Remke, A Ernst, W Werft, N Becker, G Toedt, ... The Journal of clinical investigation 118 (5), 1739-1749, 2008 | 583 | 2008 |
Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes PD Johann, S Erkek, M Zapatka, K Kerl, I Buchhalter, V Hovestadt, ... Cancer cell 29 (3), 379-393, 2016 | 539 | 2016 |
Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing Nature genetics 44 (12), 1316-1320, 2012 | 496 | 2012 |
BCAT1 promotes cell proliferation through amino acid catabolism in gliomas carrying wild-type IDH1 M Tönjes, S Barbus, YJ Park, W Wang, M Schlotter, AM Lindroth, ... Nature medicine 19 (7), 901-908, 2013 | 482 | 2013 |
Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing V Hovestadt, DTW Jones, S Picelli, W Wang, M Kool, PA Northcott, ... Nature 510 (7506), 537-541, 2014 | 445 | 2014 |
Longitudinal molecular trajectories of diffuse glioma in adults FP Barthel, KC Johnson, FS Varn, AD Moskalik, G Tanner, E Kocakavuk, ... Nature 576 (7785), 112-120, 2019 | 429 | 2019 |
Outcome Prediction in Pediatric Medulloblastoma Based on DNA Copy-Number Aberrations of Chromosomes 6q and 17q and the MYC and MYCN Loci S Pfister, M Remke, A Benner, F Mendrzyk, G Toedt, J Felsberg, ... Journal of clinical oncology 27 (10), 1627-1636, 2009 | 379 | 2009 |
Differentiation therapy exerts antitumor effects on stem-like glioma cells B Campos, F Wan, M Farhadi, A Ernst, F Zeppernick, KE Tagscherer, ... Clinical Cancer Research 16 (10), 2715-2728, 2010 | 360 | 2010 |
BCAT1 restricts αKG levels in AML stem cells leading to IDHmut-like DNA hypermethylation S Raffel, M Falcone, N Kneisel, J Hansson, W Wang, C Lutz, L Bullinger, ... Nature 551 (7680), 384-388, 2017 | 333 | 2017 |
Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome-and transcriptome-wide profiling improves stratification of prognostically distinct patient … M Weller, RG Weber, E Willscher, V Riehmer, B Hentschel, M Kreuz, ... Acta neuropathologica 129, 679-693, 2015 | 321 | 2015 |
MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema J Manner, B Radlwimmer, P Hohenberger, K Mössinger, S Küffer, ... The American journal of pathology 176 (1), 34-39, 2010 | 291 | 2010 |
Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma F Mendrzyk, B Radlwimmer, S Joos, F Kokocinski, A Benner, DE Stange, ... Journal of clinical oncology 23 (34), 8853-8862, 2005 | 286 | 2005 |
Automated array-based genomic profiling in chronic lymphocytic leukemia: development of a clinical tool and discovery of recurrent genomic alterations C Schwaenen, M Nessling, S Wessendorf, T Salvi, G Wrobel, ... Proceedings of the National Academy of Sciences 101 (4), 1039-1044, 2004 | 284 | 2004 |
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins KE Tagscherer, A Fassl, B Campos, M Farhadi, A Kraemer, BC Böck, ... Oncogene 27 (52), 6646-6656, 2008 | 248 | 2008 |